ABN AMRO INVESTMENT SOLUTIONS

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 2080520 PARIS CEDEX 008, I0

Position in TEVA

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$532,559

New position

Shares Held

15,719

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#389

of 671 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ABN AMRO INVESTMENT SOLUTIONS holds $4,253,812 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	23,120	$1,661,403
2	UTHR	UNITED THERAPEUTICS Corp	2,205	$1,194,735
3	NBIX	Neurocrine Biosciences Inc	5,133	$865,115
4	TEVA	Teva Pharmaceutical Industries Ltd This page	15,719	$532,559

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$532,559	15,719	—	Shares	Other	2026-07-23
No filing history on record for this holder in this stock.